Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunovant (IMVT)
NASDAQ:IMVT
Immunovant (IMVT) Financial Statements
731 Followers
Immunovant Financial Overview
| Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -83.47M | $ -61.78M | $ -78.01M | $ -60.42M | $ -65.78M |
| EBITDA | $ -83.15M | $ -61.43M | $ -77.67M | $ -60.08M | $ -65.45M |
| Net Income Common Stockholders | $ -75.32M | $ -58.66M | $ -73.94M | $ -59.43M | $ -63.23M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 635.37M | $ 269.93M | $ 329.96M | $ 376.53M | $ 432.61M |
| Total Assets | $ 666.37M | $ 292.07M | $ 351.22M | $ 405.50M | $ 456.24M |
| Total Debt | $ 138.00K | $ 614.00K | $ 919.00K | $ 1.22M | $ 1.51M |
| Net Debt | $ -635.23M | $ -269.31M | $ -329.04M | $ -375.31M | $ -431.10M |
| Total Liabilities | $ 48.61M | $ 40.26M | $ 51.36M | $ 43.34M | $ 41.56M |
| Stockholders Equity | $ 617.76M | $ 251.81M | $ 299.87M | $ 362.49M | $ 414.68M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -59.85M | $ -60.09M | $ -47.41M | $ -55.82M | $ -46.49M |
| Operating Cash Flow | $ -59.70M | $ -60.06M | $ -47.37M | $ -55.79M | $ -46.40M |
| Investing Cash Flow | $ -150.00K | $ -34.00K | $ -45.00K | $ -26.00K | $ -98.00K |
| Financing Cash Flow | $ 1.54M | $ 148.00K | $ 890.00K | $ 233.00K | $ 70.63M |